elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41872131-F465FCC6-2877-4822-9E66-E1E98EC94518
Q41872131-F465FCC6-2877-4822-9E66-E1E98EC94518
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41872131-F465FCC6-2877-4822-9E66-E1E98EC94518
A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia.
P2860
Q41872131-F465FCC6-2877-4822-9E66-E1E98EC94518
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41872131-F465FCC6-2877-4822-9E66-E1E98EC94518
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
67efd2f6353aecf796ea289b49dbf8e762d45e6a
P2860
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia.